Incyte buying Ariad's European operations, Iclusig rights

Incyte Corp. (NASDAQ:INCY) will acquire the European operations of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), including exclusive rights to leukemia drug Iclusig ponatinib in the EU and 22 other countries including Switzerland, Turkey and

Read the full 322 word article

User Sign In